The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans

Scand J Infect Dis. 2001;33(6):477-8. doi: 10.1080/00365540152030006.

Abstract

We studied gastrointestinal (GI) colonization by Candida albicans in patients receiving oral norfloxacin, ciprofloxacin or ofloxacin as monotherapy for urinary tract infections. Quantitative stool cultures for C. albicans were performed before, at the end and 1 week after the end of treatment. All 3 quinolones increased GI colonization by C. albicans. Ciprofloxacin caused the highest increase, which was not statistically significant.

MeSH terms

  • Adult
  • Aged
  • Anti-Infective Agents / adverse effects*
  • Anti-Infective Agents / therapeutic use
  • Candida albicans / drug effects*
  • Ciprofloxacin / adverse effects*
  • Ciprofloxacin / therapeutic use
  • Digestive System / drug effects
  • Digestive System / microbiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Norfloxacin / adverse effects*
  • Norfloxacin / therapeutic use
  • Ofloxacin / adverse effects*
  • Ofloxacin / therapeutic use
  • Urinary Tract Infections / drug therapy

Substances

  • Anti-Infective Agents
  • Ciprofloxacin
  • Ofloxacin
  • Norfloxacin